Clinical and surgical outcome of hemi thyroidectomy in low-risk papillary carcinoma thyroid
DOI:
https://doi.org/10.18203/2349-2902.isj20251164Keywords:
Hemi thyroidectomy, Low-risk papillary carcinoma thyroid, Microcarcinoma, Surgical outcome, ThyroglobulinAbstract
Background: Hemi thyroidectomy involves removing one lobe of the thyroid gland and is often considered for patients with low-risk papillary carcinoma of the thyroid. The surgical outcome generally includes a reduced risk of complications and a shorter recovery time comparing total thyroidectomy. This study aimed to assess the clinical and surgical outcomes of hemi thyroidectomy in individuals with low-risk papillary thyroid carcinoma.
Methods: This cross-sectional study was conducted in the department of ENT & Head Neck Surgery, Combined Military Hospital (CMH), Dhaka Cantonment, Dhaka, Bangladesh from 26 March 2021 to 21 July 2023. In this study, 67 patients with low-risk papillary carcinoma of the thyroid (PCT) who had undergone hemi-thyroidectomy were purposively selected. The preoperative ultrasound, FNAC and post-thyroidectomy histopathology report for all participants were documented. The data were processed & analyzed.
Results: Female patients contributed the majority at 67.2%, and 52% belonged to 31-40 yeas age group. Clinical outcomes showed that 93% of patients achieved symptom relief, while 88% were surgically cured, with a 12% recurrence rate. Complications included transient recurrent laryngeal nerve issues in 3%, permanent recurrent laryngeal nerve problems in 1.5%, transient hypothyroidism in 3%, permanent hypothyroidism in 1.5%, and hematoma in 1.5%.
Conclusion: Females are predominantly prone to low-risk papillary thyroid carcinoma. Both clinical and surgical outcomes of hemi thyroidectomy for this condition are satisfactory, making it an effective and safe treatment method.
Metrics
References
Krajewska J, Kukulska A, Oczko-Wojciechowska M, Kotecka-Blicharz A, Drosik-Rutowicz K, Haras-Gil M, et al. Early diagnosis of low-risk papillary thyroid cancer results rather in overtreatment than a better survival. Front Endocrinol (Lausanne). 2020;11:571421. DOI: https://doi.org/10.3389/fendo.2020.571421
Sterian WL. "Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian society of endocrinology and metabolism (SBEM). Archives of Endocrinol and Metabol. 2022;66(4):522-32. DOI: https://doi.org/10.20945/2359-3997000000512
Iñiguez-Ariza NM, Brito JP. Management of Low-Risk Papillary Thyroid Cancer. Endocrinol Metab (Seoul). 2018;33(2):185-94. DOI: https://doi.org/10.3803/EnM.2018.33.2.185
Ramya R. Hemithyroidectomy in papillary thyroid cancers: a prospective, single institutional surgical audit and contemplating on the clinical implications of 2015 American Thyroid Association Guidelines. Indian J Otolaryngol and Head & Neck Surg. 2023;75(2):508-16. DOI: https://doi.org/10.1007/s12070-022-03312-w
Lamartina L, Leboulleux S, Terroir M, Hartl D, Schlumberger M. An update on the management of low-risk differentiated thyroid cancer. Endocrine-related cancer. 2019;26(11):597-610. DOI: https://doi.org/10.1530/ERC-19-0294
Ito Y, Miyauchi A, Oda H. Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials, European J Surg Oncol. 2018;44(3):307-15. DOI: https://doi.org/10.1016/j.ejso.2017.03.004
Geron Y, Benbassat C, Shteinshneider M, Koren S, Or K, Markus E, et al. Long-term outcome after hemithyroidectomy for papillary thyroid cancer: a comparative study and review of the literature. Cancers (Basel). 2018;11(1):26. DOI: https://doi.org/10.3390/cancers11010026
Samuel C. Systematic review of recurrence rate after hemithyroidectomy for low-risk well-differentiated thyroid cancer. European Thyroid J. 2020;9(2):73-84. DOI: https://doi.org/10.1159/000504961
DiMarco AN, Wong MS, Jayasekara J, Clark DC, Aniss A, Glover AR, et al. Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy, BJS Open. 2019;3(3):299–304. DOI: https://doi.org/10.1002/bjs5.50137
Marco R, Tempera SE, Sessa L, Lombardi CP, Crea CD, Bellantone R. Total thyroidectomy versus thyroid lobectomy in the treatment of papillary carcinoma. Gland Surg. 2020;9(1):18-27. DOI: https://doi.org/10.21037/gs.2019.11.09
Benjamin J, Hephzibah J, Cherian AJ, Mathew D, Shanthly N, Oommen R. Is hemi-thyroidectomy adequate in low-risk differentiated thyroid cancer. World J Nucl Med. 2019;18(2):171-5. DOI: https://doi.org/10.4103/wjnm.wjnm_70_18
Zahid A, Shafiq W, Nasir KS, Loya A, Abbas Reza S, Sohail S, et al. Malignancy rate in thyroid nodule classified as Bethesda categories III & IV; a subcontinent perspectv. J Clin Tansl Endocrinol. 2021;23:100250. DOI: https://doi.org/10.1016/j.jcte.2021.100250
Song M, Sun W, Liu Q, Wang Z, Zhang H. Global scientific trends on thyroid disease in early 21st century: a bibliometric and visualized analysis. Frontiers in Endocrinology. 2024;14:1306232. DOI: https://doi.org/10.3389/fendo.2023.1306232
Zhu F, Shen Y, Zhu L, Chen L, Li F, Xie X, et al. The effect of hemithyroidectomy in papillary thyroid carcinoma with an exclusive involvement of the recurrent laryngeal nerve: a retrospective study with a propensity score-matched analysis. Curr Oncol. 2024;31:3603–14. DOI: https://doi.org/10.3390/curroncol31060265
Ahmed M, Ella A, Ihab M. effect and long-term outcome of hemithyroidectomy for patients with low-risk papillary thyroid carcinoma. J of Med in Sci Res. 2021;4(3):97. DOI: https://doi.org/10.4103/JMISR.JMISR_97_20
Suman P, Razdan SN, Wang C‑HE, Tulchinsky M, Ahmed L, Prinz RA, et al. Thyroid lobectomy for T1b‑T2 papillary thyroid cancers with high‑risk features. J Am Coll Surg. 2020;230:136–44. DOI: https://doi.org/10.1016/j.jamcollsurg.2019.09.021
Downloads
Published
How to Cite
Issue
Section
